Tuberculosis in special populations

被引:10
作者
Santin Cerezales, Miguel [1 ]
Navas Elorza, Enrique [2 ]
机构
[1] Univ Barcelona, Inst Salud Carlos III, IDIBELL,Dept Ciencias Clin, Hosp Univ Bellvitge,Serv Enfermedades Infecciosas, Barcelona, Spain
[2] Hosp Univ Ramon y Cajal, Serv Enfermedades Infecciosas, Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2011年 / 29卷
关键词
Tuberculosis; Immunosupression; Comorbidity; Immigration; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED PERSONS; FOREIGN-BORN PERSONS; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; RISK-FACTORS; TRANSMISSION;
D O I
10.1016/S0213-005X(11)70014-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The susceptibility to infection, the pathogenesis and the clinical manifestations of tuberculosis (TB) depend on the immunological status of the host. Immunological status is largely determined by age and comorbidities, but is also affected by other less well known factors. In Spain, most incidental cases of TB arise from the reactivation of remotely acquired latent infections and are favored by the aging of the population and the use of aggressive immunosuppressive therapies. The diagnosis and management of TB in these circumstances is often challenging. On the one hand, the atypical presentation with extrapulmonary involvement may delay diagnosis, and on the other, the toxicity and interactions of the antituberculous drugs frequently make treatment difficult. Immigration from resource-poor, high incidence TB countries, where the social and economic conditions are often suboptimal, adds a new challenge to the control of the disease in Spain. This chapter summarizes our current knowledge of epidemiological, clinical and treatment aspects of TB in particularly susceptible populations. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 76 条
[1]   Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology [J].
Aguado, Jose Maria ;
Torre-Cisneros, Julian ;
Fortun, Jesus ;
Benito, Natividad ;
Meije, Yolanda ;
Doblas, Antonio ;
Munoz, Patricia .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (09) :1276-1284
[2]  
Anibarro L, 2010, INT J TUBERC LUNG D, V14, P701
[3]  
[Anonymous], 1990, MMWR Recomm Rep, V39, P7
[4]  
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[5]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[6]   Tuberculosis and immigration in a health sanitary area in Madrid, Spain.: Trends in 1994-2003 [J].
Arnáez, AA ;
Martínez, JI ;
Ballesteros, LC ;
Arenales, MB .
MEDICINA CLINICA, 2005, 125 (06) :210-212
[7]  
Arora V. K., 2003, Indian Journal of Tuberculosis, V50, P13
[8]   Update on rifampin and rifabutin drug interactions [J].
Baciewicz, Anne M. ;
Chrisman, Cary R. ;
Finch, Christopher K. ;
Self, Timothy H. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 335 (02) :126-136
[9]   QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases [J].
Bartalesi, F. ;
Vicidomini, S. ;
Goletti, D. ;
Fiorelli, C. ;
Fiori, G. ;
Melchiorre, D. ;
Tortoli, E. ;
Mantella, A. ;
Benucci, M. ;
Girardi, E. ;
Cerinic, M. M. ;
Bartoloni, A. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (03) :586-593
[10]  
BINDU R, 1998, SEMIN RESPIR CRIT CA, V19, P295